Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1998
03/03/1998US5723313 ARF-p19, a novel regulator of the mammalian cell cycle
03/03/1998US5723312 Derived from insect triatoma; anticoagulants; antitumor, anticarcinogenic, and antimetastasis agents; genetic engineering
03/03/1998US5723311 Human DNA topoisomerase I α
03/03/1998US5723309 Production of subunits of soluble T cell receptors by co-transfection
03/03/1998US5723129 GnRH-leukotoxin chimeras
03/03/1998US5723128 Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
03/03/1998US5723127 Cancer therapy, vaccines; cell-mediated immune response enhancers
03/03/1998US5723126 Methods and compositions for therapeutic uses of a fibrin-specific monoclonal antibody
03/03/1998US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
03/03/1998US5723123 Process for the production of a virus-free concentrate of thrombin
03/03/1998US5723122 Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases
03/03/1998US5723121 Sugar modified interferon
03/03/1998US5723120 Method of treating an IL-6 related disease with interleukin-6 receptor antagonists
03/03/1998US5723119 Method for enhancing wound healing/repair with IL-4
03/03/1998US5723118 Therapeutic agents which are antagonists or partial agonists of human interleukin 4
03/03/1998US5723117 Use of interleukin-1 (IL-1) to inhibit development of hepatitis
03/03/1998US5723116 Decreased mortality of severe acute pancreatitis following proximal cytokine blockade
03/03/1998US5723115 Inhibition of adipose tissue development and obesity
03/03/1998US5722428 Diapase, vision defects
03/03/1998CA1339694C Human high-affinity neurotranmitter uptake system
02/1998
02/28/1998CA2212954A1 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
02/26/1998WO1998007886A1 Process for identification of genes encoding proteins having cell proliferation-promoting activity
02/26/1998WO1998007881A1 T1 receptor-like ligand i
02/26/1998WO1998007880A1 Human endokine alpha
02/26/1998WO1998007878A2 Long-term expression of gene products by transforming muscle cells
02/26/1998WO1998007877A1 A short-shafted adenoviral fiber and its use
02/26/1998WO1998007876A2 Self-replicating episomal expression vectors conferring tissue-specific gene expression
02/26/1998WO1998007872A1 Homocysteine desulphurase from the protozoan trichomonas vaginalis
02/26/1998WO1998007870A1 Novel raftk signaling molecules and uses therefor
02/26/1998WO1998007865A1 Targeting adenovirus with use of constrained peptide motifs
02/26/1998WO1998007864A1 Recombinant toxin fragments
02/26/1998WO1998007863A1 HUMAN INTERFERON τ VARIANTS
02/26/1998WO1998007862A2 Chemokine beta-16
02/26/1998WO1998007860A1 HUMAN POLYHOMEOTIC 1 (hph1) ACTS AS AN ONCOGENE
02/26/1998WO1998007859A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007858A1 HUMAN POLYHOMEOTIC 1(hphl) ACTS AS A TUMOR SUPPRESSOR
02/26/1998WO1998007855A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007854A1 Human glycine transporter
02/26/1998WO1998007853A1 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007851A2 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans
02/26/1998WO1998007850A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
02/26/1998WO1998007849A1 Madr2 tumour suppressor gene
02/26/1998WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
02/26/1998WO1998007840A1 Novel dnas and process for producing proteins by using the same
02/26/1998WO1998007838A1 Higher animal telomerase protein and gene encoding the same
02/26/1998WO1998007833A1 Compositions and methods for use of defensin
02/26/1998WO1998007832A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
02/26/1998WO1998007754A1 T1 receptor-like ligand ii
02/26/1998WO1998007752A1 Self-assembling amphiphiles for construction of peptide secondary structures
02/26/1998WO1998007751A1 A process for purifying apolipoprotein a or apolipoprotein e from human plasma
02/26/1998WO1998007750A1 Novel osteopontin derived chemotactic peptides and methods of use
02/26/1998WO1998007749A1 Novel human growth factors
02/26/1998WO1998007746A1 B1-bradykinin receptor antagonists and use thereof
02/26/1998WO1998007745A2 Compositions and methods for treating infections using analogues of indolicidin
02/26/1998WO1998007744A1 Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions
02/26/1998WO1998007743A1 Macrolides
02/26/1998WO1998007738A1 Immunoglobulin trans-spliced transcripts and uses thereof
02/26/1998WO1998007736A1 Don-1 gene and polypeptides and uses therefor
02/26/1998WO1998007735A1 Pancreas-derived plasminogen activator inhibitor
02/26/1998WO1998007696A1 Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds
02/26/1998WO1998007446A1 Protein formulations
02/26/1998WO1998007444A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
02/26/1998WO1998007442A1 Sustained-release preparation comprising erythropoietin and polylactide coglycolide
02/26/1998WO1998007441A1 Allogeneic histocompatibility complexes as mediators of cell destruction
02/26/1998WO1998007440A1 A novel antimicrobial peptide isolated from bufo bufo gargarizans
02/26/1998WO1998007438A1 Compositions and methods for skin tanning and protection
02/26/1998WO1998007435A1 Eye treatments using synthetic thyroid hormone compositions
02/26/1998WO1998007415A2 Methods for prevention of cellular proliferation and restenosis
02/26/1998WO1998007320A1 NEUTRALIZATION-SENSITIVE EPITOPES OF $i(CRYPTOSPORIDIUM PARVUM)
02/26/1998WO1998007308A2 Thrombin inhibitors
02/26/1998WO1998003652A3 P300/cbp-associated transcriptional co-factor p/caf and uses thereof
02/26/1998WO1998002546A3 Dna immunization against chlamydia infection
02/26/1998WO1998002453A3 Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor
02/26/1998WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase
02/26/1998WO1997049807A3 A novel hypertension related calcium regulated gene (hcarg)
02/26/1998WO1997049373A3 Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin
02/26/1998WO1997046681A3 Galanin receptor galr2
02/26/1998WO1997039123A3 Secreted proteins
02/26/1998WO1997022621A3 Antineoplastic peptides
02/26/1998DE19649207C1 Nucleic acid characteristic of late or early passage cells immortalised by papilloma virus
02/26/1998DE19648962C1 DNA encoding peptide(s) from papilloma virus major capsid protein
02/26/1998CA2269654A1 Long-term expression of gene products by transforming muscle cells
02/26/1998CA2264203A1 Compositions and methods for use of defensin
02/26/1998CA2264200A1 Human endokine alpha
02/26/1998CA2264192A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2263942A1 Novel osteopontin derived chemotactic peptides and methods of use
02/26/1998CA2263894A1 Novel human growth factors
02/26/1998CA2263890A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
02/26/1998CA2263875A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2263871A1 Allogeneic histocompatibility complexes as mediators of cell destruction
02/26/1998CA2263854A1 Don-1 gene and polypeptides and uses therefor
02/26/1998CA2263832A1 T1 receptor-like ligand ii
02/26/1998CA2263830A1 T1 receptor-like ligand i
02/26/1998CA2263799A1 Compositions and methods for treating infections using analogues of indolicidin
02/26/1998CA2263796A1 Self-replicating episomal expression vectors conferring tissue-specific gene expression
02/26/1998CA2263744A1 Process for identification of genes encoding proteins having cell proliferation-promoting activity
02/26/1998CA2263192A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2263189A1 A short-shafted adenoviral fiber and its use
02/26/1998CA2263141A1 Neutralization-sensitive epitopes of cryptosporidium parvum
02/26/1998CA2263140A1 Targeting adenovirus with use of constrained peptide motifs